MicroRNAs (miRNAs) play critical roles during the development of the cardiovascular system. Blocking miRNA biosynthesis in embryonic hearts through a conditional gene inactivation approach led to differential cardiac defects depending on the Cre drivers used in different studies. The goal of this study is to reveal the cardiogenic pathway that is regulated by the miRNA mechanism at midgestation, a stage that has not been evaluated in previous publications.
Introduction
TGFb signalling is critical for cardiovascular development; abnormal TGFb activities cause various congenital cardiovascular defects in both animal models and human patients. 1 -5 The intracellular signalling cascade activated by TGFb cytokines (including TGFb1, TGFb2, and TGFb3) has extensively been studied. In brief, a TGFb ligand homodimer binds and brings together the Type I and II serine/threonine kinase receptors at the cell membrane to form the ligand -receptor complex, which allows the Type II receptor to phosphorylate the Type I receptor. The activated Type I receptor subsequently phosphorylates the cytoplasmic proteins SMAD2 and SMAD3. Phosphorylated SMAD2 and SMAD3 (p-SMAD2 and p-SMAD3) associate with SMAD4 and translocate to the nucleus to regulate transcription of target genes. 6, 7 In addition to the SMAD pathway, TGFb signalling can also activate non-canonical kinase pathways. 8 -10 TGFb signalling plays critical roles during cardiogenesis. Tgfb2
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(Tgfbr1) or the type II (Tgfbr2) receptors has led to severe valvuloseptal defects. 13, 14 Intriguingly, cardiomyocyte inactivation of Tgfbr1 or Tgfbr2 did not cause obvious cardiac defects in the majority of embryos. 13, 14 The activities of the two genes in the myocardium are likely compensated by other genes encoding TGFb superfamily receptors. Even though Tgfbr1 and Tgfbr2 are not essential for myocardial development, these results do not exclude the possibility that up-regulation of these two genes in cardiomyocytes may cause heart defects. Supporting this idea, in a transgenic study, constitutively activated myocardial TGFBR1 led to the arrest of heart development at the looping stage and resulted in ventricular hypoplasia. 15 Human genetic studies provide direct evidence supporting the clinical significance of altered TGFb signalling in the aetiology of inborn cardiovascular anomalies. TGFBR1 and TGFBR2 are causal genes for Marfan syndrome and Loeys-Dietz syndrome, 16 -19 both of which are associated with CHDs.
Also, mutations in TGFB2 and SMAD3 cause syndromic aortic aneurysms. 20 -22 Significantly, mutations in these genes may either decrease or increase TGFb signalling in patients, 16 -19 indicating that maintaining the proper level of TGFb activity is critical for cardiovascular development. The microRNA (miRNA) machinery plays vital roles during cardiogenesis. 23 -25 miRNAs are evolutionarily conserved non-coding small RNA molecules that primarily act on the 3 ′ untranslated regions (UTRs) of target mRNAs to down-regulate their stability and translation efficiency. 23 -25 Genes encoding miRNAs are transcribed by RNA polymerase II/III to generate Pri-miRNAs, which are processed to Pre-miRNAs by DROSHA in the nucleus. Pre-miRNAs are exported to the cytoplasm, where they are further processed by the RNase III ribonuclease DICER to generate 22 nucleotide mature miRNAs. Therefore, DICER is required for the generation of most, if not all, functional miRNAs. In metazoans, the 'seed' sequence, referring to nucleotides 2-8 of a miRNA, is typically 100% complementary to its target. 26 To understand the cardiogenic roles of global miRNA biosynthesis, Dicer1 has been inactivated in cardiomyocytes at precursor and late gestational stages. 27 -29 These studies collectively indicate that miRNAs play complex roles at different stages. In our current study, we specifically inactivated Dicer1 in the myocardium during midgestation, a stage that has not been evaluated in published studies. We revealed that TGFb signalling is directly regulated by the miRNA machinery in developing hearts, and that such regulation is indispensable for normal myocardial wall development. Transfection System (Invitrogen) were used for transfection. miRNA mimics were purchased from Ambion. To generate reporter constructs, a 400 bp fragment within the 3 ′ UTR of mTgfbr1 containing a potential miRNA target site was cloned into the pMIR-REPORT-LUC vector (Ambion). Luciferase activities were measured using the Luciferase assay kit (Promega). A plasmid expressing a lacZ reporter driven by a constant promoter was co-transfected for normalization of transfection efficiency. LacZ activity was measured using the Beta-Glo-Assay System (Promega).
Microarray and quantitative reverse transcription-PCR analysis
Total RNA isolated with the RNeasy Plus Kit (Qiagen) from E13.5 hearts was subjected to microarray analysis using the Affymetrix GeneChip Mouse Genome 430 2.0 Array (UAB Heflin Genomic Core). Data were averaged from two independent experiments. Reverse transcription was performed using SuperScriptIII (Invitrogen). Quantitative PCR analysis was performed using LightCycler480 SYBR Green I Master (Roche) on the Roche LightCycler480 Real-Time PCR machine. Hprt was used as a loading control. The primers for RT-PCR are listed in Supplementary material online. miRNA was isolated using the mirVana miRNA Isolation Kit (Ambion) followed by quantitative reverse transcription (qRT)-PCR using the TaqMan miRNA RT Kit and TaqMan Universal PCR Master Mix (Ambion).
Purification of cardiomyocytes using a molecular Beacon
Embryonic hearts at E11.5 -12.0 were digested with 0.05% trypsin for 10 -20 min to acquire single-cell suspension. Cells were spin down and re-suspended in PBS. The molecular beacon, MHC1-MB, 35 was transfected into cells using the Neon Electroporation Transfection System. DMEM with 10% fetal bovine serum (FBS) was then added to cells. After 0.5-h recovery in a 378C cell culture incubator, cells were sorted using the FACSAria sorter in the UAB Flow Cytometry Facility core. Right after purification of cells, RNA was isolated and RT-PCR using primers for myocardial-and endocardialspecific genes was performed to confirm the purity of isolated cardiomyocytes. qRT-PCR using primers corresponding to the floxed region of Dicer1 cDNA was performed to test if expression of Dicer1 mRNA was reduced in mutants. The MHC1-MB beacon with 5 ′ 6-FAM and 3 ′ BlackHoleQuencher I can efficiently label cardiomyocytes with a high specificity 35 and was synthesized from integrated DNA technologies.
Western, immunostaining, and in situ hybridization analysis
Total protein was isolated and quantified using DC Protein Assay Kit (Biorad). For western analysis, equal amounts of protein were separated through SDS -PAGE, and transferred to the PVDF membrane (Biorad). The filter was incubated with primary antibody overnight at 48C. On the second day, the filter was washed and incubated with a horseradish peroxidase-conjugated secondary antibody (Invitrogen) for 1 h. Signals were visualized using the ECL kit (Millipore). Embryos were dissected in PBS and fixed in 4% paraformaldehyde overnight. The next day, tissues were dehydrated, cleared with Histo-Clear, and embedded in wax. Wax blocks were sectioned at 8 -10 mm. For immunofluorescence studies, embryonic sections were dewaxed, re-hydrated, treated with 10 mM sodium citrate (pH 6.0) for antigen retrieval, and incubated with primary antibodies overnight at 48C. The next day, Alexa Fluor-conjugated secondary antibodies (Invitrogen) were used to visualize the signal. Samples were counterstained with DAPI to visualize total nuclei. The primary antibodies include cleaved Caspase3 (#9661), p-SMAD2 (#3101), total SMAD2 (#3102),
phospho-Histone H3 (pH3, 06-570) (Millipore), and total SMAD3 (ThermoScientific). The anti-MLC2a antibody was provided by S. Kubalak (University of South Carolina). Section in situ hybridization analysis was performed as previously described. 36 
Deoxynucleotidyl transferase dUTP nick end labelling and EdU labelling experiments
Transferase dUTP nick end labelling (TUNEL) assays were performed using the DeadEnd Fluorescence TUNEL system (Promega). For EdU labelling experiments, E14.5 hearts were cultured in DMEM containing 10% FBS and 10 mM EdU (Invitrogen) for 2 h at 378C. Samples were then embedded in wax and sectioned. EdU signals were detected using the Click-iT-EdU Imaging Kit (Invitrogen).
Results

Inactivation of Dicer1 at midgestation leads to severe myocardial wall defects
To better understand the roles of miRNA-mediated gene regulation during cardiogenesis, we crossed male cTnt-Cre;Dicer loxP/+ mice with female Dicer loxP/loxP mice to acquire mutant animals (cTnt-Cre;Dicer
. cTnt-Cre efficiently inactivates target genes in the myocardium during midgestation. 30, 37 The Dicer1 mRNA in purified cardiomyocytes from mutant hearts (E11.5 -12.0) was reduced to ,1% of the control level (see Supplementary material online, Figure S1A and B). Western analysis confirmed reduced expression of DICER1 (see Supplementary material online, Figure S1C ). The level of mature miR1 was significantly reduced in mutants (see Supplementary material online, Figure S1D ). miR1 is highly expressed in the myocardium and its maturation relies on Dicer1. 29 Our data collectively indicated that Dicer1 was efficiently inactivated in mutant cardiomyocytes at midgestation. No mutants were identified from newborn pups, indicating lethality of mutant embryos. The ratio of living mutant embryos was close to the expected 25% through E14.5 (see Supplementary material online, Figure S2 ). At E15.5, the ratio of living mutants dropped to 15% and no living mutants could be identified beyond E16.5. Our histological examination did not reveal apparent defects in mutants until E13.5. At E14.5, the myocardial walls of mutants appeared to be spongier than those of controls ( Figure 1A and B ′ ), suggesting defects in myocardial wall compaction. The spongy ventricles in mutants became more dramatic at E15.5 ( Figure 1C and D ′ ). No defect was observed in valves of mutant hearts. In situ hybridization analysis using a Nppa probe, which specifically stains the trabecular region of left ventricles, 38 confirmed that the trabecular zone was increased and the compaction zone was decreased in mutant hearts ( Figure 1E and F ′ ). Similar results were acquired from in situ hybridization analysis using a Bmp10 probe (see Supplementary material online, Figure S3 ). Expression of cTnt was reduced, but not eliminated in some areas in the compact zone of mutant ventricles (see Supplementary material online, Figure S4 ).
Mutant hearts display abnormal cell proliferation, apoptosis, and expression of contractile proteins
To reveal the cellular defects caused by myocardial inactivation of Dicer1, we performed immunostaining studies using an anti-pH3 antibody and found significantly reduced cell proliferation in mutant hearts at E13.5 ( Figure 2A-C) . Our TUNEL analysis revealed significantly increased apoptosis in mutants ( Figure 2D-F) . Expression of a group of contractile proteins, such as Actinin, cTnC, MHC, MLC1V, and MLC2V, was reduced in mutants ( Figure 2G ), whereas expression of ACTC1, MLC2A, and Tropomyosin was not altered (see Supplementary material online, Figure S5 ). Misexpression of contractile proteins was also reported in mice with Dicer1 inactivation at a later stage. 29 
Expression of TGFBR1 is up-regulated in mutant hearts
To identify genes whose expression is regulated by Dicer1, we performed microarray analysis on control and mutant hearts at E13.5. Since miRNAs negatively regulate gene expression, we focused on the up-regulated genes in mutant hearts. A total of 17 genes were identified as up-regulated by at least 1.5-fold in mutants (see Supplementary material online, Table S1 ). Significantly, the expression of Tgfbr1 was increased by 1.9-fold, suggesting the involvement of miRNAs in regulating TGFb signalling. We confirmed that the level of Tgfbr1 mRNA was increased by qRT-PCR ( Figure 3A) and in situ hybridization analysis Protein lysates isolated from E13.5 hearts were subjected to western analysis using various antibodies. (C and D) E13.5 heart sections were subjected to in situ hybridization analysis using a Tgfbr1 probe (purple) and were counterstained with eosin (red). (E and F) Heart sections (E13.5) were immunostained with an anti-p-SMAD2 antibody (red) and a cTnt antibody (green). Identical experimental conditions were applied to control and mutant samples. Scale bars represent 50 mm.
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( Figure 3C and D) . Increased expression of the TGFBR1 protein was confirmed with western analysis ( Figure 3B ). We next compared the level of p-SMAD2 and p-SMAD3 (active form of TGFb R-SMADs) between control and mutant hearts ( Figure 3E and F ) , and confirmed the increased TGFb activity in mutant hearts. Expression of SMAD7, which is a direct downstream target of TGFb R-SMADs, 39, 40 was also increased in mutant hearts. The level of active SMAD1 (p-SMAD1) was not altered by inactivation of Dicer1, indicating that bone morphogenetic protein activity was not affected.
Tgfbr1 mRNA is regulated by multiple miRNAs
Sequence analysis using the TargetScan miRNA target prediction programme (http://www.targetscan.org/mmu_61/) identified three potential miRNA target sites within the 3 ′ UTR of Tgfbr1 that are conserved among vertebrates, including humans (see Supplementary material online, Figure S6 ). These sites are 100% matched with the 8 bp seed sequences of miR98/let7, miR128, and miR142, respectively. The three putative sites were confirmed using two additional independent miRNA target prediction programmes, including miRWalk (http://www. umm.uni-heidelberg.de/apps/zmf/mirwalk/predictedmirnagene.html) and MiRanda (http://www.ebi.ac.uk/enright-srv/microcosm/htdocs/ targets/v5/). To test whether the 3 ′ UTR of Tgfbr1 mRNA is targeted by the three miRNAs, we generated reporter constructs for each miRNA. The reporter activity for each construct decreased in a dosedependent fashion when co-transfected with its corresponding miRNA mimic ( Figure 4A-C) . A scrambled miRNA mimic did not alter the activity of these reporters (see Supplementary material online, Figure S7 ). We next showed that mature miR98 and miR128 were significantly decreased in mutants (P , 0.05, Student's t-test) ( Figure 4D ). The reduction of mature miR142 in mutants was moderate (P ¼ 0.07). Thus, miR142 is likely a long-lived miRNA. These results suggest that reduced mature miR98 and miR128 contribute to the increased expression of Tgfbr1 in mutant hearts. Finally, we showed that the three miRNAs can regulate endogenous TGFb activity. After transfection into NkL-TAg cardiomyocytes, 34 all three mimics reduced expression of TGFBR1 ( Figure 4E ), activation of SMAD2 upon TGFb stimulation ( Figure 4F and see Supplementary material online, Figure S8A ), and activity of the SBE4-Lux TGFb reporter 41 (see Supplementary material online, Figure S8B ).
Blocking TGFBR1 activity alleviates the cardiomyocyte apoptosis defect in mutant hearts in vitro
We tested whether increased TGFb activity has any detrimental effect on embryonic hearts at midgestation. Treatment of in vitro cultured ) and mutant (mut, cTnt-Cre;Dicer1 loxP/loxP ) hearts at E13.5 and were subjected to qRT-PCR analysis to detect mature miR98, miR128, and miR142. SnoRNA202 was used as a loading control. The level of signal in control hearts was set at 100%. Data were averaged from at least three independent experiments. (E) NkL-TAg cells were transfected with a scrambled control or various miRNA mimics. At 48 h after transfection, western analysis was performed to detect the expression of TGFBR1. The reduction of TGFBR1 by the miR98 mimic was moderate, and yet could be repeatedly detected from four independent experiments. (F) NkL-TAg cells harbouring the scrambled control or various miRNA mimics were treated with 0 or 5 ng/mL of TGFb1 (R&D) for 4 h, followed by western analysis using antibodies against p-SMAD2, total SMAD2, or tubulin. Reduction of p-SMAD2 was moderate in cells harbouring miR98 and yet could be repeatedly detected. $ P , 0.05; # P , 0.01 (Student's t-test).
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.5 hearts with TGFb1 did not alter cell proliferation or expression of contractile proteins ( Figure 5A-D) . Therefore, the enhanced TGFb activity does not likely contribute to abnormal cell proliferation or expression of contractile proteins as observed in Dicer1-inactivated hearts. On the contrary, TGFb treatment significantly increased cell death in cultured hearts ( Figure 5E and F ) (P , 0.01, Student's t-test). Blocking TGFBR1 activity with SB505124 42 significantly alleviated the apoptosis defect in Dicer1 mutant hearts ( Figure 5G-I) . Apoptosis in mutants treated with SB505124 was still higher than the control level, indicating that TGFBR1 blockade partially rescues the cell death defect caused by myocardial inactivation of Dicer1.
Reducing TGFb activity partially rescues the heart defects caused by inactivation of Dicer1 in vivo
We applied a genetic approach to determine whether reducing TGFb activity could alleviate the heart defects caused by Dicer1 inactivation in vivo. TGFb activity was reduced through breeding strategies using Tgfbr2 embryos). The ratio of embryos with different genotypes is listed in Table 1 . The ratio of survival of dKO embryos (2.6%) is significantly lower than the expected Mendelian ratio (12.5%) and significantly higher than that of Dicer1-sKO embryos (0%) (P , 0.01, x 2 test). Figure 6 shows an example of a living dKO embryo at E16.5. The ventricular wall of dKO hearts was thinner than controls, but did not show the spongy phenotype ( Figure 6A ′′ and B ′′ ). We did not observe any myocardial wall defect in Tgfbr2 sKO embryos. Our western analysis showed that the level of p-SMAD2 was slightly reduced in Tgfbr2 sKO embryonic hearts (see Supplementary material online, Figure S9 ). The level of p-SMAD2 in dKO embryonic hearts dropped to about the same level observed in Tgfbr2 sKO hearts, confirming the reduced TGFb activity in dKO hearts. We conclude that reducing TGFb activity can partially rescue the heart defects caused by myocardial inactivation of Dicer1 in vivo. In the developing yolk sac, expression of ActR1b (Alk4) is up-regulated in compensation for the inactivation of TGFb signalling. 43 We therefore examined the expression of ACTR1B. As shown in Supplementary material online, Figure S9 , expression of ACTR1B was slightly increased in The number in the parenthesis refers to the expected number from Mendelian ratio. 
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Tgfbr2 inactivation and dKO hearts, suggesting that Activin signalling is enhanced by inactivation of Tgfbr2. We speculate that, in the absence of Tgfbr2, SMAD2 is phosphorylated by Activin signalling in embryonic hearts.
We also examined cell proliferation/apoptosis in sKO and dKO hearts (see Supplementary material online, Figure S10) . A small group (25%) of dKO hearts showed reduced cell death; the apoptosis rate of these embryos is close to the control level, lower than that of sKO or the majority of dKO embryonic hearts. Our results therefore suggest that deletion of Tgfbr2 improves cell survival of a small group of the hearts with Dicer1 inactivated.
Discussion
miRNAs have recently emerged as highly attractive therapeutic targets/ reagents for various cardiovascular diseases. 23 -25 As such, it has become imperative to better understand the function of miRNAs during cardiovascular system development. Previous studies have tested the cardiogenic roles of global miRNA biosynthesis through heart-specific deletion of Dicer1 using different Cre drivers. Deletion of Dicer1 in cardiac progenitor cells using an Nkx2.5-Cre driver led to delayed ventricular development, pericardial oedema, and embryonic death at E12.5. 27 Deletion of Dicer1 using an independent Nkx2.5-Cre driver, which inactivates targets with subtly different spatiotemporal kinetics, led to abnormal outflow-tract patterning. 28 Myocardial inactivation of Dicer1 at late gestation using MHC-Cre resulted in dilated cardiomyopathy, heart failure, and early postnatal lethality. 29 These results collectively indicate that miRNAs play complex roles at different cardiogenic stages. To reveal the effect of blocking miRNA biosynthesis at midgestation, a stage that has not been evaluated in previous studies, we specifically inactivated Dicer1 using cTnt-Cre, which efficiently inactivates target genes in cardiomyocytes at E10.5 -11.5. 30, 37 Our current study provides novel insights into the cardiogenic roles of the miRNA regulatory machinery. A major conclusion of this study is that elevated TGFb signalling plays an important role in the heart defects caused by Dicer1 inactivation. We reveal that TGFb signalling is negatively regulated by the miRNA machinery during cardiogenesis. Ectopic expression of constitutively active TGFBR1 arrested heart development at the primitive tube stage at E9.5, suggesting that hearts are sensitive to uncontrolled TGFb activity at the looping stage. 15 How increased TGFb activity affects heart development after chamber formation has not been reported. We show that exogenous TGFb1 significantly increases cell death, and that pharmacological blockade of TGFb activity alleviates the cell death abnormality caused by myocardial inactivation of Dicer1. To reveal the in vivo relevance of enhanced TGFb activity in Dicer1 mutant hearts, we applied a genetic approach to reduce TGFb activity by deletion of Tgfbr2 in mice with Dicer1 myocardial inactivation. Tgfbr2 encodes the only known Type II receptor of TGFBR1. Significantly, a small portion of double-mutant embryos survived beyond E16.5, the stage at which no Dicer1-sKO mutant could survive to. Our results support the notion that normal TGFb activity is essential for heart development after chamber formation, and that uncontrolled TGFb activity is a major contributing factor for the heart defects in Dicer1-inactivated embryos. We previously reported that myocardial inactivation of Tgfbr2 led to a minor heart defect with a low penetrance (10%). 13 However, we did not observe any heart defect in Tgfbr2 sKO embryos in this study. This discrepancy is likely caused by different mouse backgrounds used in the two studies. In the previous study, C57BL/6 mice were used, while in the current study the mice are on a mixed C57BL/6 × 129s6 background. Reducing TGFb activity only partially alleviated the cardiac defects caused by Dicer1 inactivation. This result is expected, as other cardiogenic signalling pathways are likely also disrupted in Dicer1-inactivated hearts. The cardiac phenotypes of Dicer1-inactivated embryos are most likely caused by the combined effects of abnormal expression of multiple genes (see Supplementary material online, Table S1 ). Interaction between endocardial and myocardial cells is important for normal myocardial wall development. For example, the endocardium can promote trabeculation of the myocardium through EGF signalling. 44, 45 It is possible that increased TGFb activity in the myocardium can lead to abnormal development of endocardial cells, which in turn contributes to the abnormalities in the mutant myocardial wall. We provide evidence that the 3 ′ UTR of Tgfbr1 is directly targeted by miR98, miR128, and miR142. miR98 belongs to the let7 miRNA family, in which all members share identical seed sequences. Therefore, Tgfbr1 is likely also targeted by other let7 members. The function of let7/miR98 has been heavily studied in stem cell differentiation/proliferation, tumour suppression, and neural development. 46 Studies of miR128 and miR142 have mainly focused on their role in cancer biology. 47, 48 We provide the first evidence that these three miRNAs regulate cardiomyogenesis through directly repressing TGFBR1 expression.
Considering the broad roles of TGFb signalling in numerous biological/pathological processes, we speculate that these miRNAs also regulate TGFb activity in other cell types. Spongy myocardial wall due to non-compaction is a novel phenotype observed in the current study that has not been reported in other Dicer1 inactivation models. Non-compaction in human patients can cause congestive heart failure, arrhythmias, thromboembolic complications, and sudden death. 49 , and cTnt-Cre;Dicer1 loxP/loxP mice, and may thus play an aetiological role in non-compaction. This hypothesis is supported by our discovery that surviving Tgfbr2;Dicer1 double-mutant embryos did not show the spongy wall defect. In summary, our study on myocardial inactivation of Dicer1 during midgestation reveals critical roles of miRNA biosynthesis for myocardial wall morphogenesis. Our data support the idea that miRNA-mediated repression of Tgfbr1 expression prevents excess TGFb signalling in cardiomyocytes, thereby supporting normal heart development.
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